We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.61B
AUM Growth
+$299M
Cap. Flow
+$201M
Cap. Flow %
12.48%
Top 10 Hldgs %
46.46%
Holding
257
New
114
Increased
39
Reduced
32
Closed
33

Top Buys

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$29.2M
2
GXO icon
GXO Logistics
GXO
+$16.5M
3
HES
Hess
HES
+$15M
4
AMTM
Amentum Holdings
AMTM
+$11M
5
ASML icon
ASML
ASML
+$7.65M

Sector Composition

Rank Sector Weight
1 Healthcare 19.89%
2 Consumer Discretionary 9.44%
3 Financials 6.23%
4 Industrials 3.95%
5 Communication Services 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBIT icon
26
iShares Bitcoin Trust
IBIT
$47.1B
$14.6M 0.9%
275,000
+25,000
+10% +$1.18M
BIDU icon
27
Baidu
BIDU
$38.2B
$14.3M 0.89%
170,000
+5,000
+3% +$457K
HES
28
DELISTED
Hess
HES
$14.3M 0.88%
+107,295
New +$15M
C icon
29
Citigroup
C
$222B
$14.1M 0.87%
200,000
ALNY icon
30
PUT
Alnylam Pharmaceuticals
ALNY
$28.9B
$13.8M 0.86%
58,700
-64,600
-52% -$17M
SRPT icon
31
Sarepta Therapeutics
SRPT
$1.62B
$12.4M 0.77%
102,000
+14,778
+17% +$1.81M
LEN icon
32
PUT
Lennar Class A
LEN
$20.3B
$12.3M 0.76%
92,970
+46,485
+100% +$7.55M
APLS
33
DELISTED
Apellis Pharmaceuticals
APLS
$11.5M 0.71%
360,000
+125,000
+53% +$3.76M
VKTX icon
34
Viking Therapeutics
VKTX
$3.78B
$11.3M 0.7%
280,000
-40,000
-13% -$2.28M
CRESY
35
Cresud
CRESY
$796M
$11.2M 0.69%
892,487
+44,373
+5% +$483K
ASML icon
36
ASML
ASML
$632B
$10.8M 0.67%
15,650
+10,650
+213% +$7.65M
IOVA icon
37
Iovance Biotherapeutics
IOVA
$1.89B
$10.5M 0.65%
1,416,014
+16,014
+1% +$148K
HHH icon
38
Howard Hughes
HHH
$3.85B
$10.4M 0.64%
135,000
HRMY icon
39
Harmony Biosciences
HRMY
$2.03B
$10.3M 0.64%
300,000
ZVRA icon
40
Zevra Therapeutics
ZVRA
$575M
$10.2M 0.63%
1,225,834
+834
+0.1% +$7.12K
CZR icon
41
Caesars Entertainment
CZR
$6.05B
$10.1M 0.63%
301,900
+51,900
+21% +$2.05M
IRS.WS
42
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
$9.31M 0.58%
5,086,061
+336,061
+7% +$477K
PDD icon
43
Pinduoduo
PDD
$128B
$9.21M 0.57%
95,000
+6,000
+7% +$698K
AMTM
44
Amentum Holdings
AMTM
$5.58B
$8.94M 0.55%
+425,000
New +$11M
COF icon
45
PUT
Capital One
COF
$133B
$8.92M 0.55%
50,000
-50,000
-50% -$8.66M
KNOP icon
46
KNOT Offshore Partners
KNOP
$371M
$8.77M 0.54%
1,610,000
+39,800
+3% +$240K
WAL icon
47
Western Alliance Bancorporation
WAL
$8.89B
$8.35M 0.52%
100,000
PHAT icon
48
Phathom Pharmaceuticals
PHAT
$732M
$8.32M 0.52%
1,025,000
+15,000
+1% +$186K
NE icon
49
Noble Corp
NE
$6.55B
$8.23M 0.51%
262,118
+95,000
+57% +$3.14M
R icon
50
Ryder
R
$10B
$7.33M 0.45%
46,752
-43,248
-48% -$6.76M

Similar funds

683 Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, 683 Capital Management held 257 positions worth $1.61B, up 23% from $1.31B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

683 Capital Management deployed $201M of net new capital in Q4 2024, opening 114 new positions and adding to 39 existing holdings. Its largest new stake was Western Digital: 581,326 shares worth $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was BorgWarner, an estimated $17.9M trimmed.

  • 683 Capital Management's largest Q4 2024 buy was Western Digital: 581,326 shares worth $26.2M.
  • 683 Capital Management added most to GXO Logistics in Q4 2024, an estimated $16.5M increase.
  • 683 Capital Management's biggest Q4 2024 reduction was BorgWarner, cutting an estimated $17.9M.
  • 683 Capital Management fully exited SharkNinja in Q4 2024, selling an estimated $19.6M.
  • 683 Capital Management's ten largest holdings make up 46% of its $1.61B portfolio in Q4 2024.
  • 683 Capital Management opened 114 new positions and closed 33 in Q4 2024.
  • 683 Capital Management's portfolio value rose 23% quarter-over-quarter to $1.61B.

Based on 683 Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.